Works matching IS 03125963 AND DT 2021 AND VI 60 AND IP 10
Results: 9
Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1271, doi. 10.1007/s40262-021-01040-y
- By:
- Publication type:
- Article
Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1253, doi. 10.1007/s40262-021-01038-6
- By:
- Publication type:
- Article
The Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Systematic Review and Meta-analysis.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1291, doi. 10.1007/s40262-021-01037-7
- By:
- Publication type:
- Article
Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1361, doi. 10.1007/s40262-021-01035-9
- By:
- Publication type:
- Article
Effect of Liver Cirrhosis on the Pharmacokinetics, Metabolism, and Tolerability of Daridorexant, A Novel Dual Orexin Receptor Antagonist.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1349, doi. 10.1007/s40262-021-01028-8
- By:
- Publication type:
- Article
The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1303, doi. 10.1007/s40262-021-01026-w
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1335, doi. 10.1007/s40262-021-01025-x
- By:
- Publication type:
- Article
Estimation of Clearance and Bioavailability of Therapeutic Monoclonal Antibodies from Only Subcutaneous Injection Data in Humans Based on Comprehensive Analysis of Clinical Data.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1325, doi. 10.1007/s40262-021-01023-z
- By:
- Publication type:
- Article
Pharmacokinetics of Lorlatinib After Single and Multiple Dosing in Patients with Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer: Results from a Global Phase I/II Study.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1313, doi. 10.1007/s40262-021-01015-z
- By:
- Publication type:
- Article